The risk of intraocular pressure elevation in pediatric noninfectious uveitis

Systemic Immunosuppressive Therapy for Eye Diseases Research Group

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Abstract

Purpose To characterize the risk and risk factors for intraocular pressure (IOP) elevation in pediatric noninfectious uveitis. Design Multicenter retrospective cohort study. Participants Nine hundred sixteen children (1593 eyes) younger than 18 years at presentation with noninfectious uveitis followed up between January 1978 and December 2007 at 5 academic uveitis centers in the United States. Methods Medical records review by trained, certified experts. Main Outcome Measures Prevalence and incidence of IOP of 21 mmHg or more and 30 mmHg or more and incidence of a rise in IOP by 10 mmHg or more. To avoid underascertainment, outcomes were counted as present when IOP-lowering therapies were in use. Results Initially, 251 (15.8%) and 46 eyes (2.9%) had IOP 21 mmHg and 30 mmHg, respectively. Factors significantly associated with presenting IOP elevation included age of 6 to 12 years (versus other pediatric ages), prior cataract surgery, pars plana vitrectomy, duration of uveitis 6 months, contralateral IOP elevation, presenting visual acuity worse than 20/40, and topical corticosteroid use (in a dose-response relationship). The median follow-up was 1.25 years (interquartile range, 0.4-3.66). The estimated incidence of any observed IOP elevation to 21 mmHg, to 30 mmHg, and increase in IOP by 10 mmHg was 33.4%, 14.8%, and 24.4%, respectively, within 2 years. Factors associated with IOP elevation included pars plana vitrectomy, contralateral IOP elevation (adjusted hazard ratio [aHR], up to 9.54; P < 0.001), and the use of topical (aHR, up to 8.77 that followed a dose-response relationship; P < 0.001), periocular (aHR, up to 7.96; P < 0.001), and intraocular (aHR, up to 19.7; P < 0.001) corticosteroids. Conclusions Intraocular pressure elevation affects a large minority of children with noninfectious uveitis. Statistically significant risk factors include IOP elevation or use of IOP-lowering treatment in the contralateral eye and local corticosteroid use that demonstrated a dose-and route of administration-dependent relationship. In contrast, use of immunosuppressive drug therapy did not increase such risk. Pediatric eyes with noninfectious uveitis should be followed up closely for IOP elevation, especially when strong risk factors such as the use of local corticosteroids and contralateral IOP elevation are present.

Original languageEnglish
Pages (from-to)1987-2001
Number of pages15
JournalOphthalmology
Volume122
Issue number10
DOIs
StatePublished - 1 Oct 2015

Fingerprint

Dive into the research topics of 'The risk of intraocular pressure elevation in pediatric noninfectious uveitis'. Together they form a unique fingerprint.

Cite this